arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Ingevity Corp

NGVT
$77.81 ▲ +0.62 (+0.80%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
13 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ingevity Corp shows mixed fundamentals. On the positive side, Operating Margin (%) remains strong. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $2.8B
Dividend Yield
Revenue Growth -2.7%
Op. Margin 35.9%
ROIC 1491.1%
FCF / Share $9.14
Trailing P/E
Price / Book 93.0x
FCF Yield 11.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.17B
↓ -2.7%
Net Income Profit after all expenses
$-167.10M
↑ +61.2%
Operating Margin Operating profit as % of sales
35.9%
↑ +1.0% 91th
FCF / Share Free cash flow per share
$9.14
↑ +158.3%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
65
Financial Health
74
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 48 quarters